The Long-Term Tolerability and Efficacy of Armodafinil in Patients with Excessive Sleepiness Associated with Treated Obstructive Sleep Apnea, Shift Work Disorder, or Narcolepsy: An Open-Label Extension Study-Reference-Cited by-同舟云学术

The Long-Term Tolerability and Efficacy of Armodafinil in Patients with Excessive Sleepiness Associated with Treated Obstructive Sleep Apnea, Shift Work Disorder, or Narcolepsy: An Open-Label Extension Study

Published:2010-10-15 Issue:05 Volume:06 Page:458-466
ISSN:1550-9389
Container-title:Journal of Clinical Sleep Medicine
language:en
Short-container-title:Journal of Clinical Sleep Medicine

Author:

Black Jed E.¹²,Hull Steven G.³,Tiller Jane⁴,Yang Ronghua⁴,Harsh John R.⁵

Affiliation:

1. Actelion Pharmaceuticals, Allschwil, Switzerland

2. Stanford Sleep Disorders Clinic, Stanford University, Stanford, CA

3. Vince and Associates Clinical Research, Overland Park, KS

4. Cephalon, Inc., Frazer, PA

5. University of Southern Mississippi, Hattiesburg, MS

Publisher

American Academy of Sleep Medicine (AASM)

Subject

Neurology (clinical),Neurology,Pulmonary and Respiratory Medicine

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hits and misses with animal models of narcolepsy and the implications for drug discovery;Expert Opinion on Drug Discovery;2024-05-15

2. Recovery Mimicking “Ideal” CPAP Adherence Does Not Improve Wakefulness or Cognition in Chronic Murine Models of OSA: Effect of Wake-Promoting Agents;Archivos de Bronconeumología;2023-12

3. Recommendations for clinical management of excessive daytime sleepiness in obstructive sleep apnoea – A Delphi consensus study;Sleep Medicine;2023-12

4. Solriamfetol enhances wakefulness and improves cognition and anxiety in a murine model of OSA;Sleep Medicine;2023-07

5. Solriamfetol improves chronic sleep fragmentation-induced increases in sleep propensity and ameliorates explicit memory in male mice;SLEEP;2023-03-02